The death of Alicia Harnishfeger, discovered under a downtown bridge during a severe cold snap, has sparked conversations about systemic failures in addressing homelessness intertwined with mental health and substance abuse crises.
ProPublica has identified the two federal agents involved in the January shooting of Alex Pretti, a case marked by disputed official narratives and calls for transparency.
The Malaysian healthcare provider KPJ Healthcare Berhad is demonstrating a strengthened capacity for profitable reinvestment, with its return on capital employed rising to 11% alongside significant capital expansion, pointing to a robust operational model.
Private equity giant Thoma Bravo is exploring a sale of Imprivata, a key player in healthcare digital identity software, in a deal that could value the company at up to $7 billion, sources tell Reuters.
RBC Capital reaffirms its Outperform rating on UnitedHealth Group, citing management's commitment to long-term earnings targets, even as a lower-than-expected Medicare Advantage rate proposal triggers a sharp sell-off in the health insurer's shares.
Omega Healthcare Investors (OHI) maintains its quarterly dividend, offering a signal of stability to income-focused shareholders as the healthcare REIT navigates tenant health and leverage concerns in a challenging operating environment.
Truist Securities adjusted its price target for American Healthcare REIT (NYSE: AHR) downward slightly, while affirming a Buy rating. The move comes as the firm reassesses its outlook for the broader REIT sector heading into 2026.
While the healthcare sector has significantly outperformed the broader market, surging 17.4% in six months, not all companies are positioned to thrive. Intense competition and shifting market dynamics pose risks for some established players. We examine three stocks where investors may want to exercise caution.
The healthcare sector has surged 17.4% in six months, outpacing the S&P 500. While demographic trends fuel long-term growth, regulatory hurdles and valuation concerns demand selective investing. We analyze one company built for decades of returns and two where investors should tread carefully.
Advocate Health, the nation's third-largest nonprofit health system, is investing over $800 million in enhanced compensation and benefits for its 165,000+ employees, raising its minimum wage and expanding tuition aid, mental health support, and paid volunteer time.
Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.
After a punishing year of underperformance and operational setbacks, Baxter International faces a skeptical analyst community. While some see deep value, the consensus remains firmly on hold as the company navigates product challenges and revised guidance.
A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.
The historic Farmers' Almanac, famed for its secret weather formula, has been acquired by digital media company Unofficial Networks. The move saves the publication from shuttering, relocates its operations from Maine to New York, and promises a digital-first revival alongside a planned return to print.
A human rights group has cautioned New York state and city officials that investing public funds in Israeli government bonds may violate international law and fiduciary duties, exposing them to significant legal and financial risks.
In a sweeping decree, Burkina Faso's junta has formally dissolved the nation's political parties and seized their assets, a move analysts warn consolidates authoritarian rule and extinguishes a key pillar of democratic life amid an escalating security crisis.
A New York federal judge has dismissed murder and weapons charges against Luigi Mangione, the man accused of killing UnitedHealthcare's CEO. The ruling deals a significant setback to federal prosecutors and removes the possibility of a death penalty in the high-profile case.
Official figures reveal a sharp 26% increase in the annual cost of public sector pensions, now reaching £39bn, with taxpayers covering the bulk of the expense as employer contribution rates rise.
As demand for specialist education soars, private investors—from Abu Dhabi to private equity firms—are capitalizing on a strained system, drawing criticism for extracting profits from vulnerable children and cash-strapped councils.
Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.
